Lymphoma & Leukaemia Research Review, Issue 54

In this issue:

Oxaliplatin before ASCT in MCL
Thiotepa-based conditioning in PCNSL
Hyper-CVAD and dasatinib in CML-LBP and Ph+ ALL
Prognostic factors for progression in Ph+ ALL
Venetoclax + intensive chemo in AML or MDS
Dose-dense brentuximab vedotin in Hodgkin lymphoma
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma
Polatuzumab vedotin in large B-cell lymphomas
Low-dose decitabine as part of conditioning in AML
Radiation therapy in localised non-gastric MZL

Please login below to download this issue (PDF)

Subscribe